⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CASI News
CASI Pharmaceuticals, Inc. Ordinary Shares
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
accessnewswire.com
CASI
CASI Pharmaceuticals Appoints James Huang to Board of Directors
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
accessnewswire.com
CASI
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
accessnewswire.com
CASI